SynthesisRMD open2026

Effects of biologic and targeted synthetic disease modifying antirheumatic drugs (b/tsDMARDs) on patient-reported outcome domains in rheumatoid arthritis: a systematic review and network meta-analyses.

Luuk van Esveld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.